Company Filing History:
Years Active: 2010-2011
Title: Amy L Tsui Collins: Innovator in Biomedical Research
Introduction
Amy L Tsui Collins is a prominent inventor based in Oakland, CA. She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic antibodies. With a total of 2 patents, her work focuses on innovative solutions for treating various diseases.
Latest Patents
Amy's latest patents include groundbreaking research on antibodies to stromal cell-derived factor-1 polypeptides. These patents disclose a newly identified SDF-1 splice variant molecule, its polypeptide sequence, and the polynucleotides encoding this sequence. The patents also provide procedures for producing such polypeptides using recombinant techniques, including vectors and host cells. Furthermore, they outline methods for utilizing these polypeptides and their modulators in the treatment of diseases such as cancer, immune diseases, infectious diseases, and ischemic diseases.
Career Highlights
Amy L Tsui Collins is currently associated with Five Prime Therapeutics, Inc., where she continues to advance her research in the biomedical field. Her work has been instrumental in developing new therapeutic approaches that can potentially improve patient outcomes.
Collaborations
Some of her notable coworkers include Keting Chu and Lewis T Williams, who collaborate with her on various research projects.
Conclusion
Amy L Tsui Collins exemplifies the spirit of innovation in biomedical research, with her patents paving the way for new treatments for serious health conditions. Her contributions are vital to the ongoing advancements in medical science.